PTC THERAPEUTICS, INC. — Director's Dealing 2020

Nov 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-11-04

Reporting Person: Utter Christine Marie (SVP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-04	Common Stock	M	1567	$30.86	Acquired	11129	Direct
2020-11-04	Common Stock	S	1567	$60.20	Disposed	9562	Direct
2020-11-04	Common Stock	M	688	$30.86	Acquired	10250	Direct
2020-11-04	Common Stock	S	688	$60.00	Disposed	9562	Direct
2020-11-04	Common Stock	M	355	$18.01	Acquired	9917	Direct
2020-11-04	Common Stock	S	355	$60.00	Disposed	9562	Direct
2020-11-04	Common Stock	M	2500	$18.01	Acquired	12062	Direct
2020-11-04	Common Stock	S	2500	$60.00	Disposed	9562	Direct
2020-11-04	Common Stock	M	8055	$30.86	Acquired	17617	Direct
2020-11-04	Common Stock	S	8055	$60.20	Disposed	9562	Direct
2020-11-04	Common Stock	M	2656	$33.02	Acquired	12218	Direct
2020-11-04	Common Stock	S	2656	$60.00	Disposed	9562	Direct
2020-11-04	Common Stock	M	2656	$33.02	Acquired	12218	Direct
2020-11-04	Common Stock	S	2656	$60.00	Disposed	9562	Direct
2020-11-04	Common Stock	M	10625	$33.02	Acquired	20187	Direct
2020-11-04	Common Stock	S	10625	$60.00	Disposed	9562	Direct
2020-11-04	Common Stock	M	2656	$33.02	Acquired	12218	Direct
2020-11-04	Common Stock	S	2656	$60.00	Disposed	9562	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-04	Stock Option (Right To Buy)	$30.86	M	1567	Disposed	2026-01-03	Common Stock (1567)	Direct
2020-11-04	Stock Option (Right to Buy)	$30.86	M	688	Disposed	2026-01-03	Common Stock (688)	Direct
2020-11-04	Stock Option (Right to Buy)	$18.01	M	355	Disposed	2028-01-02	Common Stock (355)	Direct
2020-11-04	Stock Option (Right to Buy)	$18.01	M	2500	Disposed	2028-01-02	Common Stock (2500)	Direct
2020-11-04	Stock Option (Right to Buy)	$30.86	M	8055	Disposed	2026-01-03	Common Stock (8055)	Direct
2020-11-04	Stock Option (Right To Buy)	$33.02	M	2656	Disposed	2029-01-21	Common Stock (2656)	Direct
2020-11-04	Stock Option (Right to Buy)	$33.02	M	2656	Disposed	2029-01-21	Common Stock (2656)	Direct
2020-11-04	Stock Option (Right to Buy)	$33.02	M	10625	Disposed	2029-01-21	Common Stock (10625)	Direct
2020-11-04	Stock Option (Right to Buy)	$33.02	M	2656	Disposed	2029-01-21	Common Stock (2656)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right To Buy)	$490.8	2021-04-27	Common Stock (74.0)	74	Direct
Stock Option (Right To Buy)	$218.4	2022-01-10	Common Stock (21.0)	21	Direct
Stock Option (Right To Buy)	$40.45	2024-09-23	Common Stock (4688.0)	4688	Direct
Stock Option (Right To Buy)	$51.0	2025-01-02	Common Stock (17800.0)	17800	Direct
Stock Option (Right To Buy)	$11.23	2027-01-02	Common Stock (788.0)	788	Direct
Stock Option (Right To Buy)	$33.02	2029-01-21	Common Stock (10100.0)	10100	Direct
Stock Option (Right To Buy)	$51.16	2030-01-28	Common Stock (23800.0)	23800	Direct

Footnotes

F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 1, 2019.

F2: Currently exercisable.

F3: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.

F4: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.

F5: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.

F6: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.

F7: This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.